#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphoma Alexander disease Wolfram syndrome Castleman's disease Metabolic disorder Porphyria non-acute Prolymphocytic leukaemia Non-small cell lung cancer metastatic Hodgkin's disease refractory Severe myoclonic epilepsy of infancy Hypereosinophilic syndrome Alagille syndrome Ovarian cancer stage IV Becker's muscular dystrophy Transplant rejection More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment Vascular malformation – Trials in Disease Haemolytic uraemic syndrome – Treatment Antisynthetase syndrome – Basic Information Usher’s syndrome – Life with Disease Castleman’s disease – Trials in Disease Alexander disease – Diagnostics Cystic fibrosis – Basic Information Adrenocortical carcinoma – Life with Disease Small intestine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Namilumab Ecopipam Hydrochloride Omaveloxolone Isoleucine Pemafibrate Acp-204 Tartrate Alpha1H Bt8009 Emtricitabine Intestifix Dobutamine Hydrochloride Mk-6194 REGN7544 ANHYDROUS CALCIUM FOLINATE 20-HYDROXYECDYSONE Estradiol Hemihydrate Pemetrexed Zetomipzomib Bisoprolol Fumarate Sodium Iodide (131I) More therapies…

    Learn about Your Condition

    Cutaneous lupus erythematosus Developmental hip dysplasia Extra-osseous Ewing's sarcoma Myelodysplastic syndrome Haemorrhagic stroke Obstructive pancreatitis Psychotic behaviour Cervix carcinoma stage IV Escherichia infection Pulmonary sarcoidosis Breast cancer female Diabetic foot Burkitt's lymphoma Metastatic glioma Gastric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Paernu

  • A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Austria Belgium Bulgaria Czechia Estonia France +10

  • Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oseltamivir
    • Baloxavir Marboxil
    • Hydrocortisone Sodium Succinate
    Belgium Estonia France Italy The Netherlands Portugal +3

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisone Acetate
    • Fludrocortisone
    • Dexamethasone Acetate
    Czechia Estonia France Germany Greece Hungary +9

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Estonia France +12

  • Study of Efgartigimod for Adults with Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Czechia Estonia Germany Greece +4

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Inclisiran Rosuvastatin Prednisolone Hydrocortisone Sodium Succinate Abiraterone Acetate Dexamethasone Ph. Eur. Fludrocortisone Acetate Dexamethasone Sodium Phosphate Hydrocortisone Efgartigimod Alfa Glutamate Decarboxylase 2, Human, Recombinant Opevesostat Tosilate Adalimumab Colecalciferol Dexamethasone Lutikizumab Enzalutamide Atorvastatin Evolocumab Prednisone Prednisone Acetate Oseltamivir Fludrocortisone Baloxavir Marboxil Dexamethasone Acetate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Arteriosclerosis Chronic kidney disease Colitis ulcerative Dyslipidaemia Endocrine ophthalmopathy Hormone-refractory prostate cancer Hypercholesterolaemia Pneumonia Type 1 diabetes mellitus

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!